Clinical trial
Metabolic Syndrome Risk Factor in IGT: STOP-NIDDM Trial
NCT00629213
Study timeline
Registry last updated2008-03-07
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Metabolic Syndromeunresolved
Interventions
acarboseDRUG · verified · RxNorm: acarbose
placeboDRUG
Sponsors & collaborators
GWT-TUD GmbHlead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00629213 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.